Colorectal Cancer Screening in Transgender and Gender-Diverse Patients at Community Health Organizations.

Purpose: We assessed colorectal cancer (CRC) screening in community health organizations in the transgender and gender-diverse (TGD) population. Methods: Using the electronic health record data from patients served between 2014 and 2019, Poisson regression compared CRC screening by gender identity status. Results: Among 579,438 patients, 0.12% (n = 724) were TGD and 39% had no gender identity documented. There was no difference in the percentage of months spent being up-to-date by gender identity (adjusted rate ratio = 0.93, 95% confidence interval 0.86-1.01). Conclusion: In this setting, TGD and cisgender populations were screened at equivalent rates, likely reflecting these organizations' equitable care. Many patients lacked gender identity documentation.